Acuren Operating Expenses 2023-2025 | TIC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Acuren operating expenses from 2023 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Acuren operating expenses from 2023 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$215.2B
Boston Scientific (BSX)	$153.3B
Stryker (SYK)	$148.6B
EssilorLuxottica (ESLOY)	$131.1B
Medtronic (MDT)	$114.9B
Lonza Group Ag (LZAGY)	$49.8B
Haleon (HLN)	$43.1B
ResMed (RMD)	$37.8B
GE HealthCare Technologies (GEHC)	$34.8B
Agilent Technologies (A)	$32.4B
Terumo (TRUMY)	$23.9B
Koninklijke Philips (PHG)	$23.7B
Insulet (PODD)	$20B
Zimmer Biomet Holdings (ZBH)	$18.4B
Baxter (BAX)	$14.3B
Smith & Nephew SNATS (SNN)	$13.2B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.7B
Lantheus Holdings (LNTH)	$4.9B
Prestige Consumer Healthcare (PBH)	$3.7B
Perrigo (PRGO)	$3.7B
Haemonetics (HAE)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.3B
ICU Medical (ICUI)	$3B
LeMaitre Vascular (LMAT)	$1.8B
QuidelOrtho (QDEL)	$1.7B
AtriCure (ATRC)	$1.4B
AdaptHealth (AHCO)	$1.2B